TRIZLEX BIOPHARMA OÜ - 11220756 | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

TRIZLEX BIOPHARMA OÜ

Summary report

Date of report 11.11.2025

TRIZLEX BIOPHARMA OÜ

Registered
Registration code: 11220756
Founded in: 10.02.2006 (19 years)
EMTAK:

VAT:
EE101030128 (start 01.03.06)
start end
01.03.2006 -

Former names

  • TRIZLEX OÜ

Business address:

Balti Hair Studio
Tallinn, Põhja-Tallinn, Toompuiestee 35
+372 5333 7573
Opening hours:
Closed Opening Wednesday clock 9
Monday 09 - 19
Tuesday 09 - 19
Wednesday 09 - 19
Thursday 09 - 19
Friday 09 - 19
Saturday Closed
Sunday Closed

Add TRIZLEX BIOPHARMA OÜ data to your system

Add TRIZLEX BIOPHARMA OÜ data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

keywords

  • õigus- ja konsultatsiooniteenused
  • ärinõustamine

TRIZLEX BIOPHARMA OÜ

Scores and ratings

Reputation score

?
What is Reputation score?

Credit Score

?
Trustworthy

Loader
What is Credit Score?

Open the reports you want to print

Employees and salaries

TRIZLEX BIOPHARMA OÜ

Number of employees and estimated average salaries
?

TRIZLEX BIOPHARMA OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2025 III........................
2025 II........................
2025 I........................
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................
2016 II........................
2016 I........................
2015 IV........................
2015 III........................
2015 II........................
2015 I........................

Deciders and beneficiaries

TRIZLEX BIOPHARMA OÜ

Decision-makers
?

Former decision-makers

Janno Kurg
★★★★

......

Related companies scores

Credit Score: ...

Reputation score: ...

Date of birth: ......

Active relations 3

Business advice
*Every member of the management board may represent the private limited company in concluding all transactions.

TRIZLEX BIOPHARMA OÜ

History of right of representation
?
Field
Administrative Activities
Business age
19y
Beneficial country:
Estonia
 
Janno Kurg ... - ...
Margus Riistop ... - ...
2006
2009
2011
2014
2017
2020
2022
2025
2006
2008
2009
2011
2013
2015
2016
2018
2020
2022
2023
2025

TRIZLEX BIOPHARMA OÜ

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
more_horiz
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
more_horiz
..................
more_horiz
..................
more_horiz
..................
check_indeterminate_small
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

TRIZLEX BIOPHARMA OÜ

Goodwill

TRIZLEX BIOPHARMA OÜ

Taxes paid and estimated average salaries

TRIZLEX BIOPHARMA OÜ

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2025 III* ............* ..............................
2025 II* ............* ..............................
2025 I* ............* ..............................
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................
2016 IV* ............* ..............................
2016 III* ............* ..............................
2016 II* ............* ..............................
2016 I* ............* ..............................
2015 IV* ............* ..............................
2015 III* ............* ..............................
2015 II* ............* ..............................
2015 I* ............* ..............................

TRIZLEX BIOPHARMA OÜ

Sales revenue by business area

TRIZLEX BIOPHARMA OÜ

Sales revenue by country

TRIZLEX BIOPHARMA OÜ

Financial indicators and prognosis

TRIZLEX BIOPHARMA OÜ

Financial raiting: "VERY GOOD" (2025 prognosis)
2025 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

TRIZLEX BIOPHARMA OÜ

Annual reports
Year Period Submitted Report PDF
2024 01.01.2024–31.12.2024 28.06.2025 ......
2023 01.01.2023–31.12.2023 04.07.2024 ......
2022 01.01.2022–31.12.2022 10.09.2023 ......
2021 01.01.2021–31.12.2021 10.09.2022 ......
2020 01.01.2020–31.12.2020 09.10.2021 ......
2019 01.01.2019–31.12.2019 18.10.2020 ......
2018 01.01.2018–31.12.2018 05.08.2019 ......
2017 01.01.2017–31.12.2017 04.03.2018 ......
2016 01.01.2016–31.12.2016 04.03.2018 ......
2015 01.01.2015–31.12.2015 13.01.2017 ......
2014 01.01.2014–31.12.2014 24.07.2016 ......
2013 01.01.2013–31.12.2013 21.08.2014 ......
2012 01.01.2012–31.12.2012 21.08.2014 ......
2011 01.01.2011–31.12.2011 21.08.2014 ......
2010 01.01.2010–31.12.2010 15.08.2011 ......
2009 01.01.2009–31.12.2009 02.07.2010 ......
2008 01.01.2008–31.12.2008 30.06.2009 ......
2007 01.01.2007–31.12.2007 29.05.2008 ......
2006 01.01.2006–31.12.2006 15.06.2007 ......

Liabilities and debts

TRIZLEX BIOPHARMA OÜ

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

TRIZLEX BIOPHARMA OÜ

Reports and assets-liabilities overview 11.11.2025
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

TRIZLEX BIOPHARMA OÜ

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Creditors' claims ...... €

Total debt claims: ...... €

Latest events
...... ......

TRIZLEX BIOPHARMA OÜ

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2025 III* ...... €...... €...... €...... €......
2025 II* ...... €...... €...... €...... €......
2025 I* ...... €...... €...... €...... €......
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......
2016 IV* ...... €...... €...... €...... €......
2016 III* ...... €...... €...... €...... €......
2016 II* ...... €...... €...... €...... €......
2016 I* ...... €...... €...... €...... €......
2015 IV* ...... €...... €...... €...... €......
2015 III* ...... €...... €...... €...... €......
2015 II* ...... €...... €...... €...... €......
2015 I* ...... €...... €...... €...... €......

TRIZLEX BIOPHARMA OÜ

Bailiff's enforcement proceedings as of 11.11.2025
?

Bailiff's enforcement proceedings MISSING

TRIZLEX BIOPHARMA OÜ

Regulations of the Payment Order Department as of 11.11.2025
?

Regulations of the Payment Order Department MISSING

TRIZLEX BIOPHARMA OÜ

Court orders in the register as of 11.11.2025
?

Court order MISSING

TRIZLEX BIOPHARMA OÜ

Decisions of the Consumer Disputes Committee as of 11.11.2025
?

Consumer disputes MISSING

TRIZLEX BIOPHARMA OÜ

Court hearings as of 11.11.2025
?

Court hearings MISSING

TRIZLEX BIOPHARMA OÜ

Rulings as of 11.11.2025
?

Court settlemets MISSING

TRIZLEX BIOPHARMA OÜ

Notices and announcements as of 11.11.2025
?

Announcements MISSING

Marketing

Business network

TRIZLEX BIOPHARMA OÜ

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

TRIZLEX BIOPHARMA OÜ

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.

We value your privacy

We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.